Page last updated: 2024-08-21

3-hydroxyflavone and Carcinoma, Renal Cell

3-hydroxyflavone has been researched along with Carcinoma, Renal Cell in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chang, HR; Chiou, HL; Hsieh, MH; Hsieh, YH; Lin, CL; Tsai, JP; Yang, SF1

Other Studies

1 other study(ies) available for 3-hydroxyflavone and Carcinoma, Renal Cell

ArticleYear
Fisetin Suppresses the Proliferation and Metastasis of Renal Cell Carcinoma through Upregulation of MEK/ERK-Targeting CTSS and ADAM9.
    Cells, 2019, 08-21, Volume: 8, Issue:9

    Topics: ADAM Proteins; Antineoplastic Agents; Carcinoma, Renal Cell; Cathepsins; Cell Movement; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Flavonoids; Flavonols; Humans; Kidney Neoplasms; MAP Kinase Signaling System; Membrane Proteins; Molecular Structure; Neoplasm Metastasis; Structure-Activity Relationship; Tumor Cells, Cultured

2019